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Recently, concern about exposure to electromagnetic fields has 
been expressed. 14 Although a definite cause and effect be-
tween these fields and cancer has not been established, we 
report a case in which the patient, who slept on a magnetic 
mattress for 5 years, developed myeloma. 
Case Report 
A 71-year-old Japanese man, who had retired from his posi-
tion as an accountant supervisor, fell and fractured his T-12 
vertebrae. He had anemia, monoclonal protein spikes in his 
urine and serum, an abnormal bone scan with multiple areas of 
increased activity, and IgA myeloma was confirmed by bone 
marrow examination. 
For 5 years he had slept on a magnetic mattress, about 72 in x 
32 in x 2 in, and a pillow, about 24 in x12 in x 2 in, with 20 mm 
round, flat magnets, each with a magnetic flux of 900 Gauss, 
1.09T, evenly distributed: 88 in the mattress, 40 in the pillow. A 
Geiger count disclosed no radiation from the magnets. 
Discussion 
The etiology of myeloma, believed to be a malignant disease 
of the bone marrow, is unknown.s Recently, artificially gener-
ated sources of EMF have been suggested as a risk factor for 
cancer. Whether natural or static magnetic field exposure is a 
risk factor is unknown.6 
No reports were found in a 10-year Medline literature search 
for EMF exposure that caused myeloma. In this patient, there is 
no proof that the prolonged magnetic field exposure from the 
mattress and pillow caused his myeloma. However, the possibil-
ity of prolonged static magnetic field exposure inducing trans-
formation of benign plasma cells to malignant myeloma cells is 
raised. 
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R. Michael Blaese MD, chief of clinical gene therapy at the 
National Center for Human Genome Research, was introduced 
by Chris Gulbrandsen MD, dean of the UH John A. Bums 
School of Medicine, to an audience of about 40 persons during 
the Robert T. Wong Lectureship that was open to the general 
public. Dr Blaese had been lecturing all that week in Honolulu. 
For this, his last lecture, he chose the general topic of "Gene 
Therapy." 
Electing to discuss the genetic aberrations that afflict humans, 
Blaese revealed the impressive figure that there are some 4,000 
so-called inherited diseases in humans. 
In simple terms, gene therapy consists of inserting genes into 
a human cell to program its function, similar to slipping a 
program diskette into a computer disk drive. The newly pro-
grammed gene is then inserted into the nucleus of a cell of a 
patient. This is not easy to do. Research, however, has revealed 
a successful way of doing this by means of using transfer agents, 
the best and most practical of which are retroviruses (RV), which 
contain only 3 genes, as compared with 100,000 genes in a 
human. The introduced good (or bad) gene carried by the RVis 
integrated into the chromosome that has a "long-term repeater" 
at both ends to assure that the successful implant is not short-
lived. 
At this point, Blaese digressed a bit to point out that it is 
possible to transfer desirable, as well as undesirable, genes in or 
out. This poses an ethical dilemma because no one wants to see 
a monster grow; nor should a theoretical gene that would 
guarantee an IQ of 250 be experimented with. Consequently, 
such research has strict monitors overlooking it: one is a special 
advisory committee of the NIH and the other is the FDA. The 
United States is the only country, so far, that has this control in 
operation. 
Under guidelines, therefore, gene therapy is limited to non-
germinal organs and tissues in order to avoid the possibility of 
the inserted or extracted gene affecting the next generations. 
Somatic cell tissue ex-vivo is an acceptable source for research, 
but reproductive cell tissue is specifically forbidden. 
Additionally, it has been found that tissues of the bone mar-
row, muscle, liver and kidney can be experimented on, but that 
the nerve cells and brain cells are not usable because, unlike the 
cells of the rest of the human body, these do not replicate 
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